Literature DB >> 12385450

Development and validation of a model to diagnose cirrhosis in patients with hepatitis C.

Vivek Kaul1, Frank K Friedenberg, Leonard E Braitman, Uzma Anis, Nayere Zaeri, Javid Fazili, Steven K Herrine, Kenneth D Rothstein.   

Abstract

OBJECTIVE: Although noninvasive markers predictive of cirrhosis in patients with chronic hepatitis C have been examined, none has proved sufficiently accurate for clinical use. The aim of this study was to develop an accurate model that can be easily used by clinicians to predict the probability of cirrhosis in hepatitis C patients from readily available clinical and laboratory information.
METHODS: We identified 264 consecutive patients with established chronic hepatitis C infection and extracted multiple physical examination and biochemical variables (recorded before liver biopsy). Similar data were extracted from charts at another hospital.
RESULTS: Logistic regression identified the following independent predictors of cirrhosis: platelet count < or = 140,000/ mm3, spider nevi, AST > 40 IU/L, and male gender. Male and female patients with normal values for platelet count and AST and no spider nevi had low probabilities of cirrhosis: 1.8% (95% CI = 0.4-7) and 0.03% (95% CI = 0.003-0.04), respectively. Male patients with abnormal values on all three other predictors had a probability of cirrhosis of 99.8% (95% CI = 98.7-100). Over 48% of study patients had a low (< or = 1.8%) or a very high (> or = 99.8%) predicted probability of cirrhosis. The model had area under the receiver operating characteristic curve of 0.938 (95% CI = 0.91-0.97) and 93.4% in an internal validation. The model accurately distinguished patients with and without cirrhosis (area under the receiver operating characteristic curve = 93.3%) in 102 hepatitis C patients from another hospital.
CONCLUSIONS: In patients with hepatitis C, four readily available variables together predict cirrhosis accurately. Successful validation in hepatitis C patients at another hospital with lower prevalence of cirrhosis suggests this model's potential for broad applicability.

Entities:  

Mesh:

Year:  2002        PMID: 12385450     DOI: 10.1111/j.1572-0241.2002.06040.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.

Authors:  Xu-Dong Liu; Jian-Lin Wu; Jian Liang; Tao Zhang; Qing-Shou Sheng
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

2.  MR Elastography of Liver Disease: State of the Art.

Authors:  Jun Chen; Meng Yin; Kevin J Glaser; Jayant A Talwalkar; Richard L Ehman
Journal:  Appl Radiol       Date:  2013-04

3.  Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma.

Authors:  Daiki Miki; Hiroshi Aikata; Kiminori Uka; Hiromi Saneto; Tomokazu Kawaoka; Takahiro Azakami; Shintaro Takaki; Soo Cheol Jeong; Michio Imamura; Yoshiiku Kawakami; Shoichi Takahashi; Toshiyuki Itamoto; Toshimasa Asahara; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

4.  Quantifying liver cirrhosis by extracting significant features from MRI T2 image.

Authors:  Ming-Hong Hshiao; Po-Chou Chen; Jo-Chi Jao; Yung-Hui Huang; Chen-Chang Lee; Shih-Yu Chao; Li-Wei Lin; Tai-Been Chen
Journal:  ScientificWorldJournal       Date:  2012-06-18

Review 5.  Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection.

Authors:  Sumit Dahal; Smrity Upadhyay; Rashmi Banjade; Prajwal Dhakal; Nabin Khanal; Vijaya Raj Bhatt
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-03-01       Impact factor: 2.576

6.  Non-biopsy methods to determine hepatic fibrosis.

Authors:  Carmen Fierbinteanu-Braticevici; Monica Purcarea
Journal:  J Med Life       Date:  2009 Oct-Dec

7.  A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.

Authors:  Ivan Gentile; Nicola Coppola; Giuseppe Pasquale; Raffaele Liuzzi; Maria D'Armiento; Maria Emma Di Lorenzo; Nicolina Capoluongo; Antonio Riccardo Buonomo; Evangelista Sagnelli; Filomena Morisco; Nicola Caporaso; Guglielmo Borgia
Journal:  Hepat Mon       Date:  2013-05-08       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.